Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 6186 matches for

An internationally recognised centre of excellence for biomedical and clinical research and teaching

Bodleian Libraries update - Dec 2023 - Wellbeing | inductions | Training

Vacancies for Members of Congregation

Oxford University Hospitals launches new mRNA cancer vaccine trial for patients with head and neck cancers

The first patient in Oxfordshire has been treated in an mRNA cancer vaccine trial at Oxford University Hospitals NHS Foundation trust (OUH). The trial, led locally by Dr Ketan Shah, consultant clinical oncologist at OUH, marks a significant milestone in the national cancer vaccine advance.

MSD Research Staff Forum update: Discussing employment experience

Researcher representatives and advocates shared ideas on how to enhance and enrich the employment experience for MSD Researchers

Antibiotic resistance genes are spread more widely between bacteria than previously thought

A new study published in The Lancet Microbe has found that the transfer of antibiotic resistance genes between different bacteria is considerably more widespread than previously thought.

Race to cure type 1 diabetes gets a new boost

Radcliffe Department of Medicine (RDM) group awarded £2.55 million for diabetes research.

Winners of the Medical Research Foundation Festive Science Image Competition 2023

Winners of the Medical Research Foundation’s second Festive Science Image Competition, run in partnership with the Medical Research Council (MRC), were announced on Tuesday. Three winners were selected, with one researcher from the Nuffield Department of Clinical Neurosciences (NDCN) winning the second place and two researchers from the Department of Oncology were highly commended.

Researchers develop a blood test to identify individuals at risk of developing Parkinson’s disease

Research carried out at the University of Oxford has led to the development of a new blood-based test to identify the pathology that triggers Parkinson’s disease before the main symptoms occur. This could allow clinicians to screen for those individuals at high risk of developing the disease and facilitate the timely introduction of precision therapies that are currently at clinical trial stage.

Nuffield Department of Population Health’s Dr Tammy Tong awarded a UKRI Future Leaders Fellowship

Armed to the hilt: Study solves mystery behind bacteria’s extensive weaponry

A new study led by the University of Oxford has shed light on why certain species of bacteria carry astonishing arsenals of weapons. The new findings, published in the journal Nature Ecology & Evolution, could help us to engineer microbes that can destroy deadly pathogens, reducing our reliance on antibiotics.

Kennedy Trust gift to help drive forward research into inflammatory and musculoskeletal diseases at Oxford

Two professorships in translational medicine have been endowed at the Kennedy Institute of Rheumatology thanks to a generous gift from the Kennedy Trust for Rheumatology Research.

Clinicians, practices, and patients all have a part to play in dealing with risks of remote consulting, new Oxford-led study reveals

While most remote GP consultations are safe, the 'Remote by Default' study finds that GP consultations conducted remotely carry more risk for patients with some urgent conditions.

Nuffield Department of Primary Care Health Sciences set to deliver clinical trials expertise to China National Biotec Group in new collaboration

The training initiative builds the foundations to explore further collaborations encompassing joint research efforts, leadership programmes, and a shared commitment to advancing clinical trials.

Oxford-Harrington Rare Disease Centre named in first global initiative for children with rare diseases

In the autumn statement on Wednesday 22 November, the government announced its support for the Rare Therapies Launch Pad, a new programme that will develop regulatory pathways for children with rare conditions to access individualised therapies.

Unlocking the secrets of the gut microbiome

Undaunted by its complexity, Professor Emma Slack is pioneering new methods of engineering the body’s largest microbiome to improve health and protect against disease.

Oxford-led study shows how AI can detect antibiotic resistance in as little as 30 minutes

To mark World Antimicrobial Awareness Week, researchers supported by the Oxford Martin Programme on Antimicrobial Resistance Testing at the University of Oxford have reported advances towards a novel and rapid antimicrobial susceptibility test that can return results within as little as 30 minutes - significantly faster than current gold-standard approaches.

Antimicrobial resistance is a silent killer that leads to 5 million deaths a year. Solutions must include the poor

Microbes such as bacteria, viruses, parasites and fungi form part of our everyday lives – they live in us, on us and around us. We need them for healthy digestion, immune function, and the synthesis of essential nutrients, and we depend on them for farming and industrial processes. But microbes also cause disease in people, animals and plants.

Flies neglect food and endure shocks to seek a dopamine reward

New research published in nature, led by Department of Physiology, Anatomy and Genetics (DPAG) scientists Dr Kristijan Jovanoski and Professor Scott Waddell at the Centre for Neural Circuits and Behaviour, reveals dopamine systems can cause flies to seek reward despite negative consequences

Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa

The Pandemic Sciences Institute (PSI) has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.

£4.3m boost for Oxford-Glasgow spinout tackling antimicrobial resistance

Glox Therapeutics, a company pioneering the development of precision antibiotics to combat antimicrobial resistance, has raised £4.3M in early-stage funding to develop effective targeted therapeutics against antibiotic-resistant gram-negative bacteria.

Load More